The paradoxical association between brain natriuretic peptide and obesity in patients with acute myocardial infarction

Experimental and Clinical Cardiology

Volumn 20, Issue 6, 2014, Pages 145-153

  Rezende, Paulo Cury ^a,b   Katz, Marcelo ^a   Pesaro, Antonio E P ^a   Kanamaru, Fabio ^a   Makdisse, Marcia R P ^a   Correa, Alessandra G ^a   Forlenza, Luciano M A ^a   Franken, Marcelo ^a,b   Fava, Anderson N ^a   Buzatto, Leandro L ^a   Serrano Jr , Carlos V ^a,b  

^a HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Myocardial infarction; Natriuretic peptides; body mass index; Obesity

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CREATININE; TROPONIN I;

ACUTE HEART INFARCTION; AGED; ARTICLE; BODY MASS; DISEASE ASSOCIATION; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBESITY; OBSERVATIONAL STUDY; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

EID: 84904301581     PISSN: 12056626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Morrow DA, Antman EM, Charlesworth A, Cairns R, Murphy SA, de Lemos JA, et al. TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation. 2000;102(17):2031-7.
2. de Lemos JA, Morrow DA, Bentley JH, Omland T, Sabatine MS, McCabe CH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. The New England journal of medicine. 2001;345(14):1014-21.
3. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. The New England journal of medicine. 2002;347(3):161-7. (Pubitemid 34764819)
4. Januzzi JL, Jr., Camargo CA, Anwaruddin S, Baggish AL, Chen AA, Krauser DG, et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. The American journal of cardiology. 2005;95(8):948-54. (Pubitemid 40487743)
5. Clerico A, Giannoni A, Vittorini S, Passino C. Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones. American journal of physiology Heart and circulatory physiology. 2011;301(1):H12-20.
6. Weber M, Hamm C. Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine. Heart. 2006;92(6):843-9. (Pubitemid 43799232)
7. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Wilson PW, et al. Impact of obesity on plasma natriuretic peptide levels. Circulation. 2004;109(5):594-600. (Pubitemid 38198866)
8. Mehra MR, Uber PA, Park MH, Scott RL, Ventura HO, Harris BC, et al. Obesity and suppressed B-type natriuretic peptide levels in heart failure. Journal of the American College of Cardiology. 2004;43(9):1590-5. (Pubitemid 38561338)
9. Dessi-Fulgheri P, Sarzani R, Tamburrini P, Moraca A, Espinosa E, Cola G, et al. Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients. Journal of hypertension. 1997;15(12 Pt 2):1695-9. (Pubitemid 28029666)
10. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Journal of the American College of Cardiology. 2000;36(3):959-69.
11. Makdisse M, Katz M, Correa Ada G, Forlenza LM, Perin MA, de Brito Junior FS, et al. Effect of implementing an acute myocardial infarction guideline on quality indicators. Einstein. 2013;11(3):357-63.
12. Anand IS, Fisher LD, Chiang YT, Latini R, Masson S, Maggioni AP, et al. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation. 2003;107(9):1278-83. (Pubitemid 36314411)
13. Suzuki S, Yoshimura M, Nakayama M, Mizuno Y, Harada E, Ito T, et al. Plasma level of B-type natriuretic peptide as a prognostic marker after acute myocardial infarction: a long-term follow-up analysis. Circulation. 2004;110(11):1387-91. (Pubitemid 39238015)
14. Garcia-Alvarez A, Sitges M, Delgado V, Ortiz J, Vidal B, Poyatos S, et al. Relation of plasma brain natriuretic peptide levels on admission for ST-elevation myocardial infarction to left ventricular end-diastolic volume six months later measured by both echocardiography and cardiac magnetic resonance. The American journal of cardiology. 2009;104(7):878-82.
15. Bruder O, Jensen C, Jochims M, Farazandeh M, Barkhausen J, Schlosser T, et al. Relation of B-type natriuretic peptide (BNP) and infarct size as assessed by contrast-enhanced MRI. International journal of cardiology. 2010;144(1):53-8.
16. Mayr A, Mair J, Schocke M, Klug G, Pedarnig K, Haubner BJ, et al. Predictive value of NT-pro BNP after acute myocardial infarction: relation with acute and chronic infarct size and myocardial function. International journal of cardiology. 2011;147(1):118-23.
17. Damman P, Beijk MA, Kuijt WJ, Verouden NJ, van Geloven N, Henriques JP, et al. Multiple biomarkers at admission significantly improve the prediction of mortality in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. Journal of the American College of Cardiology. 2011;57(1):29-36.
18. Eggers KM, Venge P, Lind L. Prognostic usefulness of the change in N-terminal pro B-type natriuretic peptide levels to predict mortality in a single community cohort aged >/= 70 years. The American journal of cardiology. 2013;111(1):131-6.
19. Daniels LB, Maisel AS. Natriuretic peptides. Journal of the American College of Cardiology. 2007;50(25):2357-68. (Pubitemid 50011582)
20. Sugisawa T, Kishimoto I, Kokubo Y, Makino H, Miyamoto Y, Yoshimasa Y. Association of plasma B-type natriuretic peptide levels with obesity in a general urban Japanese population: the Suita Study. Endocrine journal. 2010;57(8):727-33.
21. McCord J, Mundy BJ, Hudson MP, Maisel AS, Hollander JE, Abraham WT, et al. Relationship between obesity and B-type natriuretic peptide levels. Archives of internal medicine. 2004;164(20):2247-52. (Pubitemid 39452986)
22. Krauser DG, Lloyd-Jones DM, Chae CU, Cameron R, Anwaruddin S, Baggish AL, et al. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy. American heart journal. 2005;149(4):744-50.
23. Choi SG, Jeong MH, Ahn Y, Cho JG, Kang JC, Chae SC, et al. Relationship between obesity and N-terminal brain natriuretic Peptide level as a prognostic value after acute myocardial infarction. Korean circulation journal. 2010;40(11):558-64.
24. Lorgis L, Cottin Y, Danchin N, Mock L, Sicard P, Buffet P, et al. Impact of obesity on the prognostic value of the N-terminal pro-B-type natriuretic peptide (NT-proBNP) in patients with acute myocardial infarction. Heart. 2011;97(7):551-6.
25. Diercks DB, Roe MT, Mulgund J, Pollack CV, Jr., Kirk JD, Gibler WB, et al. The obesity paradox in non-ST-segment elevation acute coronary syndromes: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association Guidelines Quality Improvement Initiative. American heart journal. 2006;152(1):140-8. (Pubitemid 44040849)
26. Angeras O, Albertsson P, Karason K, Ramunddal T, Matejka G, James S, et al. Evidence for obesity paradox in patients with acute coronary syndromes: a report from the Swedish Coronary Angiography and Angioplasty Registry. European heart journal. 2013;34(5):345-53.
27. Alpert MA, Hashimi MW. Obesity and the heart. The American journal of the medical sciences. 1993;306(2):117-23. (Pubitemid 23242737)
28. Dessi-Fulgheri P, Sarzani R, Rappelli A. The natriuretic peptide system in obesity-related hypertension: new pathophysiological aspects. Journal of nephrology. 1998;11(6):296-9. (Pubitemid 29071219)
29. Clerico A, Fontana M, Vittorini S, Emdin M. The search for a pathophysiological link between gender, cardiac endocrine function, body mass regulation and cardiac mortality: proposal for a working hypothesis. Clinica chimica acta; international journal of clinical chemistry. 2009;405(1-2):1-7.
30. Pasquali R. Obesity and androgens: facts and perspectives. Fertility and sterility. 2006;85(5):1319-40.
31. Kawano H, Nagayoshi Y, Soejima H, Tanaka Y, Hokamaki J, Miyamoto S, et al. B-type natriuretic peptide after hormone therapy in postmenopausal women with chest pain and normal coronary angiogram. Menopause. 2008;15(2):352-6. (Pubitemid 351354999)
32. Lam CS, Cheng S, Choong K, Larson MG, Murabito JM, Newton-Cheh C, et al. Influence of sex and hormone status on circulating natriuretic peptides. Journal of the American College of Cardiology. 2011;58(6):618-26.
33. Guida B, Trio R, Pecoraro P, Gerardi MC, Laccetti R, Nastasi A, et al. Impedance vector distribution by body mass index and conventional bioelectrical impedance analysis in obese women. Nutrition, metabolism, and cardiovascular diseases : NMCD. 2003;13(2):72-9. (Pubitemid 38569444)
34. Chumlea WC, Schubert CM, Sun SS, Demerath E, Towne B, Siervogel RM. A review of body water status and the effects of age and body fatness in children and adults. The journal of nutrition, health & aging. 2007;11(2):111-8. (Pubitemid 46725287)